Literature DB >> 11142414

Mitochondrial permeability transition is a central coordinating event in N-(4-hydroxyphenyl)retinamide-induced apoptosis.

N Hail1, R Lotan.   

Abstract

The inhibitory effects of N-(4-hydroxyphenyl)retinamide (4HPR) on the process of carcinogenesis are not fully understood and may result from its ability to induce apoptosis in transformed cells. This study investigated the apoptotic properties of 4HPR in four human cutaneous squamous cell carcinoma cell lines. Apoptosis induction, detected by the terminal deoxynucleotidyl transferase dUTP nick end labeling method, occurred in a dose- and time-dependent fashion after treatment with 4HPR. 4HPR promoted reactive oxygen species (ROS) determined by oxidation of 2',7'-dichlorofluorescin. 4HPR-induced ROS, and apoptosis could be inhibited by L-ascorbic acid. Rhodamine 123 retention revealed that 4HPR treatment promoted a gradual dissipation of mitochondrial inner transmembrane potential, and this could be inhibited by L-ascorbic acid, implying that mitochondrial permeability transition was involved in apoptosis induction. Cyclosporin A and bongkrekic acid inhibited dissipation of mitochondrial inner transmembrane potential, ROS production, and DNA fragmentation after exposure to 4HPR, demonstrating that mitochondrial permeability transition was a central coordinating feature of 4HPR-induced apoptosis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11142414

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  13 in total

1.  The hydroxyl functional group of N-(4-hydroxyphenyl)retinamide mediates cellular uptake and cytotoxicity in premalignant and malignant human epithelial cells.

Authors:  Numsen Hail; Ping Chen; Michael F Wempe
Journal:  Free Radic Biol Med       Date:  2010-10-23       Impact factor: 7.376

2.  Selective apoptosis induction by the cancer chemopreventive agent N-(4-hydroxyphenyl)retinamide is achieved by modulating mitochondrial bioenergetics in premalignant and malignant human prostate epithelial cells.

Authors:  Numsen Hail; Ping Chen; Jadwiga J Kepa
Journal:  Apoptosis       Date:  2009-07       Impact factor: 4.677

3.  Streptozotocin Induced Neurotoxicity Involves Alzheimer's Related Pathological Markers: a Study on N2A Cells.

Authors:  Joyshree Biswas; Poonam Goswami; Sonam Gupta; Neeraj Joshi; Chandishwar Nath; Sarika Singh
Journal:  Mol Neurobiol       Date:  2015-04-01       Impact factor: 5.590

4.  Dihydroorotate dehydrogenase is required for N-(4-hydroxyphenyl)retinamide-induced reactive oxygen species production and apoptosis.

Authors:  Numsen Hail; Ping Chen; Jadwiga J Kepa; Lane R Bushman; Colin Shearn
Journal:  Free Radic Biol Med       Date:  2010-04-24       Impact factor: 7.376

5.  Endoplasmic Reticulum Stress Plays a Key Role in Rotenone-Induced Apoptotic Death of Neurons.

Authors:  Poonam Goswami; Sonam Gupta; Joyshree Biswas; Neeraj Joshi; Supriya Swarnkar; Chandishwar Nath; Sarika Singh
Journal:  Mol Neurobiol       Date:  2014-11-28       Impact factor: 5.590

6.  N-(4-hydroxyphenyl)retinamide-induced apoptosis triggered by reactive oxygen species is mediated by activation of MAPKs in head and neck squamous carcinoma cells.

Authors:  H-J Kim; N Chakravarti; N Oridate; C Choe; F-X Claret; R Lotan
Journal:  Oncogene       Date:  2006-05-04       Impact factor: 9.867

7.  Morphological and functional changes of mitochondria in apoptotic esophageal carcinoma cells induced by arsenic trioxide.

Authors:  Zhong-Ying Shen; Jian Shen; Qiao-Shan Li; Cai-Yun Chen; Jiong-Yu Chen; Zeng Yi
Journal:  World J Gastroenterol       Date:  2002-02       Impact factor: 5.742

8.  Guanabenz mitigates the neuropathological alterations and cell death in Alzheimer's disease.

Authors:  Abhishek Singh; Parul Gupta; Shubhangini Tiwari; Amit Mishra; Sarika Singh
Journal:  Cell Tissue Res       Date:  2022-02-23       Impact factor: 5.249

9.  Role for PKC δ in Fenretinide-Mediated Apoptosis in Lymphoid Leukemia Cells.

Authors:  Vivian R Ruvolo; Kul B Karanjeet; Todd F Schuster; Rhoderick Brown; Yibin Deng; Edward Hinchcliffe; Peter P Ruvolo
Journal:  J Signal Transduct       Date:  2010-01-01

10.  A phase I study of intravenous fenretinide (4-HPR) for patients with malignant solid tumors.

Authors:  Jacob S Thomas; Anthony B El-Khoueiry; Barry J Maurer; Susan Groshen; Jacek K Pinski; Everardo Cobos; David R Gandara; Heinz J Lenz; Min H Kang; C Patrick Reynolds; Edward M Newman
Journal:  Cancer Chemother Pharmacol       Date:  2021-01-10       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.